Literature DB >> 6107618

Alzheimer-like cholinergic deficiency in Down syndrome.

C M Yates, J Simpson, A F Maloney, A Gordon, A H Reid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6107618     DOI： 10.1016/s0140-6736(80)92137-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  31 in total

1.  Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice.

Authors:  Christy M Kelley; Brian E Powers; Ramon Velazquez; Jessica A Ash; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2014-04-15       Impact factor: 3.215

Review 2.  Down syndrome and the complexity of genome dosage imbalance.

Authors:  Stylianos E Antonarakis
Journal:  Nat Rev Genet       Date:  2016-12-28       Impact factor: 53.242

Review 3.  Molecular biological search for human genes encoding cholinesterases.

Authors:  H Soreq; A Gnatt
Journal:  Mol Neurobiol       Date:  1987 Spring-Summer       Impact factor: 5.590

4.  Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.

Authors:  H Godridge; G P Reynolds; C Czudek; N A Calcutt; M Benton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

5.  Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia.

Authors:  Sylvia E Perez; Jennifer C Miguel; Bin He; Michael Malek-Ahmadi; Eric E Abrahamson; Milos D Ikonomovic; Ira Lott; Eric Doran; Melissa J Alldred; Stephen D Ginsberg; Elliott J Mufson
Journal:  Acta Neuropathol       Date:  2019-02-07       Impact factor: 17.088

Review 6.  Improving Memory and Cognition in Individuals with Down Syndrome.

Authors:  Michael S Rafii
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

7.  Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Stephen D Ginsberg; Melissa J Alldred; Barbara J Strupp; Elliott J Mufson
Journal:  Dev Neurobiol       Date:  2019-06-09       Impact factor: 3.964

8.  Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.

Authors:  M B Schapiro; J V Haxby; C L Grady; R Duara; N L Schlageter; B White; A Moore; M Sundaram; S M Larson; S I Rapoport
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

9.  Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Jessica A Ash; Brian E Powers; Ramon Velazquez; Melissa J Alldred; Milos D Ikonomovic; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

10.  Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.

Authors:  Lisi Flores-Aguilar; M Florencia Iulita; Olivia Kovecses; Maria D Torres; Sarah M Levi; Yian Zhang; Manor Askenazi; Thomas Wisniewski; Jorge Busciglio; A Claudio Cuello
Journal:  Brain       Date:  2020-12-01       Impact factor: 13.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.